Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19

13 Jun 2022

Abstract excerpt

COVID-19 is primarily known as a respiratory disease caused by SARS-CoV-2. However, neurological symptoms such as memory loss, sensory confusion, severe headaches, and even stroke are reported in up to 30% of cases and can persist even after the infection is over (long COVID). These neurological symptoms are thought to be produced by the virus infecting the central nervous system, however we don't understand the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Long-Term Effects of COVID-19
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35697699
DOI: 10.1038/s41467-022-30932-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19PMID 35697699Read ↗

Neurotoxic Amyloidogenic Peptides Identified in the Proteome of SARS-COV2: Potential Implications for Neurological Symptoms in COVID-19Semantic proximity Read ↗

Neurotoxic Amyloidogenic Peptides in the Proteome of SARS-COV2: Potential Implications for Neurological Symptoms in COVID-19Semantic proximity Read ↗

SARS-CoV-2 Spike protein S2 subunit modulates γ-secretase and enhances amyloid-β production in COVID-19 neuropathySemantic proximity Read ↗

SARS-CoV-2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?Semantic proximity Read ↗

Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological ManifestationsSemantic proximity Read ↗

SARS-CoV-2 infection leads to Tau pathological signature in neuronsSemantic proximity Read ↗

Neurologic and neuropsychiatric symptoms in long-COVID 19 syndrome: a systematic reviewSemantic proximity Read ↗

Tau protein aggregation associated with SARS-CoV-2 main proteaseSemantic proximity Read ↗

Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromesSemantic proximity Read ↗

Molecular Neuropathology and Cerebrospinal Fluid Diagnostic Biomarkers of SARS-Cov2 Infection in Central Nervous System– A Scoping Review ProtocolSemantic proximity Read ↗

Deterioration of neuroimmune homeostasis in Alzheimer’s Disease patients who survive a COVID-19 infectionSemantic proximity Read ↗

SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viabilitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.